Literature DB >> 16267782

Frequent expression of neuroendocrine markers in mucinous tubular and spindle cell carcinoma of the kidney.

N Kuroda1, O Hes, E Miyazaki, T Shuin, H Enzan.   

Abstract

Mucinous tubular and spindle cell carcinoma (MTSCC) is a new tumorous entity which has been recently established. In this article, we examined the expression of neuroendocrine markers including neuron specific enolase (NSE), chromogranin A and synaptophysin in 16 cases of MTSCC using immunohistochemistry. The sex ratio (male: female) of the patients was 4:12. In normal kidney, distal tubules or collecting ducts were positive for NSE, but no structures were positive for chromogranin A or synaptophysin. All MTSCCs showed a positive reaction for NSE. Additionally, fifteen of sixteen neoplasms (93.8%) with MTSCC showed the expression of either chromogranin A or synaptophysin or both. Finally, it is possible that MTSCC may be one of renal neoplasms which frequently exhibit the neuroendocrine differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16267782     DOI: 10.14670/HH-21.7

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  4 in total

1.  Primary large cell neuroendocrine carcinoma of the kidney.

Authors:  Pavel Dundr; Michael Pesl; Ctibor Povýsil; Lenka Bauerová; Viktor Soukup
Journal:  Pathol Oncol Res       Date:  2009-07-07       Impact factor: 3.201

2.  Mucinous tubular and spindle cell carcinoma of the kidney: imaging features.

Authors:  V Anik Sahni; Michelle S Hirsch; Cheryl A Sadow; Stuart G Silverman
Journal:  Cancer Imaging       Date:  2012-03-05       Impact factor: 3.909

Review 3.  Mucinous tubular and spindle cell renal cell carcinoma: a review of clinicopathologic aspects.

Authors:  Ming Zhao; Xiang-Lei He; Xiao-Dong Teng
Journal:  Diagn Pathol       Date:  2015-09-17       Impact factor: 2.644

4.  Renal mucinous and tubular spindle cell carcinoma: a clinicopathological study of 4 cases.

Authors:  Ayman Gaafar; Carla Valentí; Celina Echevarria; Juan B Laforga; José I López
Journal:  Ann Saudi Med       Date:  2006 Nov-Dec       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.